Literature DB >> 19017962

Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation.

Suman Bandyopadhyay1, Meixiao Long, Harry Z Qui, Adam T Hagymasi, Aaron M Slaiby, Marianne A Mihalyo, Hector L Aguila, Robert S Mittler, Anthony T Vella, Adam J Adler.   

Abstract

We compared how CD4 vs CD8 cells attain the capacity to express the effector cytokine IFN-gamma under both immunogenic and tolerogenic conditions. Although the Ifng gene locus was epigenetically repressed in naive Ag-inexperienced CD4 cells, it had already undergone partial remodeling toward a transcriptionally competent configuration in naive CD8 cells. After TCR stimulation, CD8 cells fully remodeled the Ifng locus and gained the capacity to express high levels of IFN-gamma more rapidly than CD4 cells. Enforced dual costimulation through OX40 and 4-1BB redirected CD8 cells encountering soluble exogenous peptide to expand and differentiate into IFN-gamma and TNF-alpha double-producing effectors rather than becoming tolerant. Despite this and the stronger tendency of CD8 compared with CD4 cells to differentiate into IFN-gamma-expressing effectors, when parenchymal self-Ag was the source of tolerizing Ag, enforced dual costimulation selectively boosted expansion but did not push effector differentiation in CD8 cells while both expansion and effector differentiation were dramatically boosted in CD4 cells. Notably, enforced dual costimulation was able to push effector differentiation in CD8 cells encountering cognate parenchymal self-Ag when CD4 cells were simultaneously engaged. Thus, the ability of enforced OX40 plus 4-1BB dual costimulation to redirect CD8 cells to undergo effector differentiation was unexpectedly influenced by the source of tolerizing Ag and help was selectively required to facilitate CD8 cell effector differentiation when the tolerizing Ag derived from self.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017962      PMCID: PMC2846364          DOI: 10.4049/jimmunol.181.11.7728

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

Review 1.  Functions of CD8 T-cell subsets secreting different cytokine patterns.

Authors:  T R Mosmann; L Li; S Sad
Journal:  Semin Immunol       Date:  1997-04       Impact factor: 11.130

2.  Differential T cell receptor-mediated signaling in naive and memory CD4 T cells.

Authors:  D L Farber; O Acuto; K Bottomly
Journal:  Eur J Immunol       Date:  1997-08       Impact factor: 5.532

3.  Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma.

Authors:  B Bogen
Journal:  Eur J Immunol       Date:  1996-11       Impact factor: 5.532

4.  Activation and migration of CD8 T cells in the intestinal mucosa.

Authors:  S K Kim; D S Reed; W R Heath; F Carbone; L Lefrançois
Journal:  J Immunol       Date:  1997-11-01       Impact factor: 5.422

Review 5.  Cellular responses to interferon-gamma.

Authors:  U Boehm; T Klamp; M Groot; J C Howard
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  CD8(+) T cell-mediated spontaneous diabetes in neonatal mice.

Authors:  D J Morgan; R Liblau; B Scott; S Fleck; H O McDevitt; N Sarvetnick; D Lo; L A Sherman
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

7.  Hypomethylation of the interferon-gamma gene correlates with its expression by primary T-lineage cells.

Authors:  A J Melvin; M E McGurn; S J Bort; C Gibson; D B Lewis
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

Review 8.  Mechanism and biological significance of CD4-mediated cytotoxicity.

Authors:  S Hahn; R Gehri; P Erb
Journal:  Immunol Rev       Date:  1995-08       Impact factor: 12.988

9.  Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor.

Authors:  J Kirberg; A Baron; S Jakob; A Rolink; K Karjalainen; H von Boehmer
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

10.  Reentry of T cells to the adult thymus is restricted to activated T cells.

Authors:  D B Agus; C D Surh; J Sprent
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Science gone translational: the OX40 agonist story.

Authors:  Andrew D Weinberg; Nicholas P Morris; Magdalena Kovacsovics-Bankowski; Walter J Urba; Brendan D Curti
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

2.  An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.

Authors:  Payal Mittal; Rebecca Abblett; Joseph M Ryan; Adam T Hagymasi; Archibald Agyekum-Yamoah; Julia Svedova; Steven L Reiner; Marie-Clare St Rose; Matthew P Hanley; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2018-01-05       Impact factor: 5.422

3.  CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.

Authors:  Harry Z Qui; Adam T Hagymasi; Suman Bandyopadhyay; Marie-Clare St Rose; Raghunath Ramanarasimhaiah; Antoine Ménoret; Robert S Mittler; Scott M Gordon; Steven L Reiner; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

4.  Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.

Authors:  Eric F Tewalt; Jarish N Cohen; Sherin J Rouhani; Cynthia J Guidi; Hui Qiao; Shawn P Fahl; Mark R Conaway; Timothy P Bender; Kenneth S Tung; Anthony T Vella; Adam J Adler; Lieping Chen; Victor H Engelhard
Journal:  Blood       Date:  2012-09-19       Impact factor: 22.113

Review 5.  Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?

Authors:  Joseph M Ryan; Jeffrey S Wasser; Adam J Adler; Anthony T Vella
Journal:  Expert Opin Biol Ther       Date:  2016-02-25       Impact factor: 4.388

6.  Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells.

Authors:  Joseph F Grosso; Monica V Goldberg; Derese Getnet; Tullia C Bruno; Hung-Rong Yen; Kristin J Pyle; Edward Hipkiss; Dario A A Vignali; Drew M Pardoll; Charles G Drake
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

7.  Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy.

Authors:  Payal Mittal; Marie-Clare St Rose; Xi Wang; Joseph M Ryan; Jeffrey S Wasser; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2015-11-11       Impact factor: 5.422

8.  The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.

Authors:  Marie-Clare St Rose; Harry Z Qui; Suman Bandyopadhyay; Marianne A Mihalyo; Adam T Hagymasi; Robert B Clark; Adam J Adler
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

9.  In vitro and in vivo differentiated effector CD8 T cells display divergent histone acetylation patterns within the Ifng locus.

Authors:  Suman Bandyopadhyay; Harry Z Qui; Adam J Adler
Journal:  Immunol Lett       Date:  2009-02-03       Impact factor: 3.685

10.  CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion.

Authors:  Marie-Clare St Rose; Roslyn A Taylor; Suman Bandyopadhyay; Harry Z Qui; Adam T Hagymasi; Anthony T Vella; Adam J Adler
Journal:  Immunol Cell Biol       Date:  2013-01-08       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.